NYSE:COR - New York Stock Exchange, Inc. - US03073E1055 - Common Stock - Currency: USD
290.11
-1.25 (-0.43%)
The current stock price of COR is 290.11 USD. In the past month the price increased by 2.73%. In the past year, price increased by 32.54%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
MCK | MCKESSON CORP | 21.47 | 89.06B | ||
CAH | CARDINAL HEALTH INC | 19.06 | 36.84B | ||
HSIC | HENRY SCHEIN INC | 14.89 | 8.74B | ||
AHCO | ADAPTHEALTH CORP | 15.68 | 1.21B | ||
AHG | AKSO HEALTH GROUP | N/A | 653.59M | ||
OMI | OWENS & MINOR INC | 4.41 | 531.48M | ||
WGRX | WELLGISTICS HEALTH INC | N/A | 128.81M | ||
ATPC | AGAPE ATP CORP | N/A | 111.52M | ||
COSM | COSMOS HEALTH INC | N/A | 12.73M | ||
VRAX | VIRAX BIOLABS GROUP LTD | N/A | 4.34M |
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 42,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
CENCORA INC
1 West First Avenue
Conshohocken PENNSYLVANIA 80202 US
CEO: Paul E. Szurek
Employees: 42000
Phone: 16107277000
The current stock price of COR is 290.11 USD. The price decreased by -0.43% in the last trading session.
The exchange symbol of CENCORA INC is COR and it is listed on the New York Stock Exchange, Inc. exchange.
COR stock is listed on the New York Stock Exchange, Inc. exchange.
22 analysts have analysed COR and the average price target is 308.5 USD. This implies a price increase of 6.34% is expected in the next year compared to the current price of 290.11. Check the CENCORA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CENCORA INC (COR) has a market capitalization of 56.20B USD. This makes COR a Large Cap stock.
CENCORA INC (COR) currently has 42000 employees.
CENCORA INC (COR) has a support level at 288.65. Check the full technical report for a detailed analysis of COR support and resistance levels.
The Revenue of CENCORA INC (COR) is expected to grow by 9.88% in the next year. Check the estimates tab for more information on the COR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CENCORA INC (COR) has a dividend yield of 0.77%. The yearly dividend amount is currently 2.1. Check the full fundamental report for a detailed analysis of COR dividend history, reliability and sustainability.
CENCORA INC (COR) will report earnings on 2025-07-29, after the market close.
The PE ratio for CENCORA INC (COR) is 19.56. This is based on the reported non-GAAP earnings per share of 14.83 and the current share price of 290.11 USD. Check the full fundamental report for a full analysis of the valuation metrics for COR.
The outstanding short interest for CENCORA INC (COR) is 3.63% of its float. Check the ownership tab for more information on the COR short interest.
ChartMill assigns a technical rating of 10 / 10 to COR. When comparing the yearly performance of all stocks, COR is one of the better performing stocks in the market, outperforming 91.75% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to COR. COR has only an average score on both its financial health and profitability.
Over the last trailing twelve months COR reported a non-GAAP Earnings per Share(EPS) of 14.83. The EPS increased by 15.32% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 0.55% | ||
ROA | 2.38% | ||
ROE | 143.53% | ||
Debt/Equity | 6.01 |
ChartMill assigns a Buy % Consensus number of 77% to COR. The Buy consensus is the average rating of analysts ratings from 22 analysts.
For the next year, analysts expect an EPS growth of 15.99% and a revenue growth 9.88% for COR